Endobronchial Valve Systems Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Duckbill Shaped, and Umbrella Shaped), By Material (Silicon, Nitinol, and Polyester), By End User (Hospitals, Clinical Research Center, Ambulatory Surgery Center, and Others), and Region Forecast 2020-2031

Endobronchial Valve Systems Market size was valued at US$ 209.4 million in 2024 and is expected to reach US$ 319.1 million by 2031, growing at a significant CAGR of 6.2% from 2025-2031. Endobronchial valves are gaining significance currently owing to the rising prevalence of emphysema, and chronic obstructive pulmonary disease (COPD) in the world. The demand for endobronchial valves has augmented as a result of patients' and healthcare workers’ growing knowledge of these advantages. It can provide minimally invasive surgery in which the placement of this device is done to support COPD patients in breathing. The ongoing treatment provided by various health centers and institutions is driving research and development activities to grow and expand.

The need for these game-changing medical devices is ultimately boosted by developments in valve technology, which widen their field of use and increase their efficacy. The increasing number of research studies focusing on revising the advancements in endobronchial valves is likely to assist researchers in designing advanced endobronchial valves. These research studies are initiating new growth opportunities by revealing the potential assistances of endobronchial valve devices in the global space. However, complications associated with the insertion of endobronchial valves, the high cost associated with the endobronchial valves, side effects associated with the valves, and unmet needs are the factors likely to obstruct the market.

Key Developments:

• In September 2023, Boston Scientific Corporation acquired the Relievant Medsystems, Inc., a privately held medical technology company which has launched and marketed the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a type of chronic low back pain.
• In July 2023, Olympus Corporation (Olympus), a global MedTech company dedicated to making people’s lives healthier, safer, and more fulfilling, announced the launch of the “Kenya Endoscopy Human Resource Development Support Project for the Diagnosis of Gastrointestinal Diseases”.